The government shutdown is poised to become the longest in US history this week as economic pain points continue to mount. It was the worst weekend yet at airports. Meanwhile, clarity is expected ...
Chevron Lummus Global (CLG) announced an agreement that will enhance CLG's catalyst business by reshaping how it develops, ...
Williamsburg Therapy Group (WTG), a premium, tech-forward, doctoral-level-only mental health practice, has been selected by Thatch as its exclusive in-person mental health provider on the Thatch ...
In recognition of C. diff Awareness Month, LPOXY Therapeutics, Inc. is drawing attention to the ongoing burden of Clostridioides difficile infection, a leading cause of serious healthcare-associated ...
W. R. Grace & Co. (Grace), a leading global supplier of specialty chemicals and solutions that enable industries to enhance modern life, today announced it has acquired Chevron U.S.A. Inc.'s (Chevron) ...
OFD Life Sciences, a division of Oregon Freeze Dry, today announced two key appointments: Steven Brown as Vice President of Quality Assurance and Regulatory Affairs, and Ian Yates as Director of ...
Railway infrastructure company L.B. Foster (NASDAQ:FSTR) missed Wall Street’s revenue expectations in Q3 CY2025, with sales ...
Woldenberg, who runs two educational-toy businesses near Chicago, says the BubblePlush Yoga Ball Buddies, designed to help kids control their emotions, has been hit especially hard by Trump’s ...
Noodles & Company (NASDAQ: NDLS), the fast-casual favorite known for craveable, globally inspired noodle dishes, is reminding consumers to think beyond pizza this holiday season. According to a new ...
The Reform UK leader used a speech in London on Monday to promise sweeping deregulation, arguing the UK had ‘squandered’ ...
The semiconductor components maker posted revenue of $1.55 billion in the period, also beating Street forecasts. Ten analysts surveyed by Zacks expected $1.52 billion. For the cur ...
Initial funding of $25 million from the first of four tranches Facility strengthens Kyverna’s financial flexibility, further supporting advancement of its late-stage indications in generalized ...